ADHD Therapy May Aid Cognition, Impulse Control in Parkinson’s
A medicine approved to treat attention deficit hyperactivity disorder (ADHD), called atomoxetine, could help to improve thinking and impulse control…
Articles by Patricia Inácio, PhD
Telehealth, Wearable Sensors Show Life Quality Gains in Small Study
Telehealth, together with wearable sensors that accurately monitor symptoms like tremor, may help to improve quality of life for people…
Gum Disease Periodontitis Linked to Increased Risk of Parkinson’s
Periodontitis, or gum disease, may increase the risk of Parkinson’s disease, according to a large population-based study conducted in…
Identifying Role of Proteins in Nerve Cells of Living Brain Possible
A new technique allowed researchers to label with specificity proteins inside neurons of the striatum — a brain region involved…
Trial Testing Oral Therapy Anle138b Now Enrolling Patients in UK
A Phase 1 clinical trial in the U.K. is recruiting patients with mild to moderate Parkinson’s to assess…
Australian Study to Test Pool Walking for Non-motor Symptoms
An upcoming Australian study will investigate the potential benefits of pool walking — walking in a swimming pool versus on…
Parkinson’s Foundation Awards $2.2M in Community Health Grants
The Parkinson’s Foundation has awarded over $2.2 million in community health grants to 143 programs that will benefit Parkinson’s disease patients across…
Phase 2 Trial Planned for FHL-301 in Treating Early Stage Parkinson’s
Forest Hills Lab announced that it has U.S. Food and Drug Administration (FDA) permission to open a Phase 2 trial into…
FDA Places DA01, Cell Therapy for Advanced Parkinson’s, on Fast Track
The U.S. Food and Drug Administration (FDA) has given fast track designation to the investigational cell therapy DA01, now in a clinical…
Ipsen Acquires Global Rights to Mesdopetam
Ipsen has entered into an exclusive worldwide licensing agreement with Integrative Research Laboratories (IRLAB) to develop and commercialize…